Literature DB >> 25546756

Immunoglobulin (Ig) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN.

J-M Léger1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25546756      PMCID： PMC4285485          DOI： 10.1111/cei.12505

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  How long is IVIg effective in multifocal motor neuropathy?

Authors:  F Terenghi; A Cappellari; A Bersano; M Carpo; S Barbieri; E Nobile-Orazio
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

2.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.

Authors: 
Journal:  J Peripher Nerv Syst       Date:  2010-12       Impact factor: 3.494

3.  Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.

Authors:  J-M Léger; K Viala; F Cancalon; T Maisonobe; B Gruwez; T Waegemans; P Bouche
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

Review 4.  Multifocal motor neuropathy: current concepts and controversies.

Authors:  Eduardo Nobile-Orazio; Alberto Cappellari; Alberto Priori
Journal:  Muscle Nerve       Date:  2005-06       Impact factor: 3.217

5.  Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study.

Authors:  J P Azulay; O Blin; J Pouget; J Boucraut; F Billé-Turc; G Carles; G Serratrice
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

6.  Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.

Authors:  Thomas Harbo; Henning Andersen; Johannes Jakobsen
Journal:  Neurology       Date:  2010-10-12       Impact factor: 9.910

7.  Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.

Authors:  E A Cats; W-L van der Pol; S Piepers; H Franssen; B C Jacobs; R M van den Berg-Vos; J B Kuks; P A van Doorn; B G van Engelen; J J Verschuuren; J H Wokke; J H Veldink; L H van den Berg
Journal:  Neurology       Date:  2010-08-31       Impact factor: 9.910

8.  Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.

Authors:  Filip Eftimov; Marinus Vermeulen; Rob J de Haan; Leonard H van den Berg; Ivo N van Schaik
Journal:  J Peripher Nerv Syst       Date:  2009-06       Impact factor: 3.494

9.  Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.

Authors:  L H Van den Berg; H Kerkhoff; P L Oey; H Franssen; I Mollee; M Vermeulen; F G Jennekens; J H Wokke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 10.  Intravenous immunoglobulin for multifocal motor neuropathy.

Authors:  I N van Schaik; L H van den Berg; R de Haan; M Vermeulen
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18
View more
  3 in total

1.  An idiopathic thrombocytopenic purpura with polyneuropathy.

Authors:  Valeria Katchan; Paula David; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies.

Authors:  Jeffrey A Allen; Melvin Berger; Luis Querol; Krista Kuitwaard; Robert D Hadden
Journal:  J Peripher Nerv Syst       Date:  2018-04-19       Impact factor: 3.494

3.  Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.

Authors:  Satoshi Kuwabara; Sonoko Misawa; Masahiro Mori; Yuta Iwai; Kazuhide Ochi; Hidekazu Suzuki; Hiroyuki Nodera; Akira Tamaoka; Masahiro Iijima; Tatsushi Toda; Hiroo Yoshikawa; Takashi Kanda; Ko Sakamoto; Susumu Kusunoki; Gen Sobue; Ryuji Kaji
Journal:  J Peripher Nerv Syst       Date:  2018-04-24       Impact factor: 3.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.